“수원시청오피여탑 ☞ yeotop3.com ◈감상해보는◈수원시청오피✭수원시청휴게텔✢수원시청풀싸롱ⅷ수원시청키스방☜수원시청안마✴수원시청OP”的搜索结果，显示 261-270 项，共有 14659 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

4. 泌尿科- 临床试验- 妙佑医疗国际

   This clinical trial is designed to assess the safety, dosing, and preliminary efficacy of a novel penile traction device on correcting deformities relating ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...